These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2057915)

  • 1. Influence of tryptophan modification upon digestion of antithrombin III by elastase.
    Scully MF; Shah N; Ellis V; Kakkar VV
    Thromb Haemost; 1991 Apr; 65(4):351-4. PubMed ID: 2057915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chemical modification of tryptophan residues on the properties of human antithrombin III.
    Shah N; Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1990 Feb; 57(3):343-52. PubMed ID: 2315891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of thrombin- and elastase-modified human antithrombin III.
    Gettins P; Harten B
    Biochemistry; 1988 May; 27(10):3634-9. PubMed ID: 3408716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7559-66. PubMed ID: 3584127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan modification by 2-hydroxy-5-nitrobenzyl bromide studied by MALDI-TOF mass spectrometry.
    Strohalm M; Kodícek M; Pechar M
    Biochem Biophys Res Commun; 2003 Dec; 312(3):811-6. PubMed ID: 14680838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin binding and protease inhibitor activity of chemically modified antithrombin III.
    Blackburn MN; Smith RL; Sibley CC; Johnson VA
    Ann N Y Acad Sci; 1981; 370():700-7. PubMed ID: 6791550
    [No Abstract]   [Full Text] [Related]  

  • 8. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue.
    Blackburn MN; Sibley CC
    J Biol Chem; 1980 Feb; 255(3):824-6. PubMed ID: 7356660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin promotes the inactivation of antithrombin by neutrophil elastase.
    Jordan RE; Kilpatrick J; Nelson RM
    Science; 1987 Aug; 237(4816):777-9. PubMed ID: 3649921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tryptophan residues in heparin-antithrombin interactions.
    Karp GI; Marcum JA; Rosenberg RD
    Arch Biochem Biophys; 1984 Sep; 233(2):712-20. PubMed ID: 6486808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
    Huntington JA; Olson ST; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inactivation of antithrombin III by serum elastase in patients with surgical infections.
    Cohen JR; Sarfati I; Birnbaum E; Benacquista T; Wise L
    Am Surg; 1990 Nov; 56(11):665-7. PubMed ID: 2240857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human granulocytic elastase on isolated human antithrombin III.
    Jochum M; Lander S; Heimburger N; Fritz H
    Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):103-12. PubMed ID: 6783500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
    Chang WS; Harper PL
    Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III, a serpin family protease inhibitor, is a major heparin binding protein in porcine aqueous humor.
    Rao PV; Allingham RR; Herndon LW; Epstein DL
    Biochem Biophys Res Commun; 2000 May; 272(1):1-5. PubMed ID: 10872794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7552-8. PubMed ID: 3584126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.